- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $215.1M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $212M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $400K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $39.1M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $315.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $324.4M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $712M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $718.5M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $358.3M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $371.4M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $738.9M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $755.2M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $85.3M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $50.3M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 35.13M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $600K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $17M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $92.7M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $105.6M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.29 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.29 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $73.9M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.3M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $5.2M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $82.6M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $225.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $307.8M |